Konieczynska M, Natorska J, Zabczyk M, Undas A
Arch Med Sci. 2025; 20(6):1770-1783.
PMID: 39967936
PMC: 11831339.
DOI: 10.5114/aoms/197357.
Boffa M, Koschinsky M
Biochem J. 2024; 481(19):1277-1296.
PMID: 39302109
PMC: 11555715.
DOI: 10.1042/BCJ20240037.
Harb T, Ziogos E, Blumenthal R, Gerstenblith G, Leucker T
Eur Heart J Open. 2024; 4(5):oeae064.
PMID: 39219855
PMC: 11365507.
DOI: 10.1093/ehjopen/oeae064.
Zubiran R, Neufeld E, Dasseux A, Remaley A, Sorokin A
Cardiol Ther. 2024; 13(3):465-491.
PMID: 39031302
PMC: 11333429.
DOI: 10.1007/s40119-024-00376-3.
Volgman A, Koschinsky M, Mehta A, Rosenson R
J Am Heart Assoc. 2024; 13(12):e033654.
PMID: 38879448
PMC: 11255763.
DOI: 10.1161/JAHA.123.033654.
Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of Atherosclerosis.
Qin T, Ma T, Huang K, Lu S, Zhong J, Li J
Curr Atheroscler Rep. 2024; 26(8):383-394.
PMID: 38878139
PMC: 11236888.
DOI: 10.1007/s11883-024-01215-5.
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease.
Akyol O, Yang C, Woodside D, Chiang H, Chen C, Gotto A
Curr Atheroscler Rep. 2024; 26(7):317-329.
PMID: 38753254
PMC: 11192678.
DOI: 10.1007/s11883-024-01209-3.
Oxidized phospholipids in cardiovascular disease.
Tsimikas S, Witztum J
Nat Rev Cardiol. 2023; 21(3):170-191.
PMID: 37848630
DOI: 10.1038/s41569-023-00937-4.
Lipoprotein(a) As a Potential Predictive Factor for Earlier Aortic Valve Replacement in Patients with Bicuspid Aortic Valve.
Krzesinska A, Nowak M, Mickiewicz A, Chyla-Danil G, Cwiklinska A, Koper-Lenkiewicz O
Biomedicines. 2023; 11(7).
PMID: 37509461
PMC: 10376971.
DOI: 10.3390/biomedicines11071823.
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications.
Koutsogianni A, Liamis G, Liberopoulos E, Adamidis P, Florentin M
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242533
PMC: 10222947.
DOI: 10.3390/ph16050750.
The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis.
Jamialahmadi T, Reiner Z, Alidadi M, Kroh M, Almahmeed W, Ruscica M
Biomed Res Int. 2022; 2022:8435133.
PMID: 36033567
PMC: 9402303.
DOI: 10.1155/2022/8435133.
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
Coassin S, Kronenberg F
Atherosclerosis. 2022; 349:17-35.
PMID: 35606073
PMC: 7613587.
DOI: 10.1016/j.atherosclerosis.2022.04.003.
Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review.
Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh S, Chello M
Biomedicines. 2022; 10(3).
PMID: 35327504
PMC: 8945192.
DOI: 10.3390/biomedicines10030702.
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study.
Nurmohamed N, Collard D, Reeskamp L, Kaiser Y, Kroon J, Tromp T
Atherosclerosis. 2022; 341:43-49.
PMID: 34995986
PMC: 8690577.
DOI: 10.1016/j.atherosclerosis.2021.12.008.
Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition.
Vuorio A, Strandberg T, Raal F, Santos R, Kovanen P
Atheroscler Plus. 2021; 43:3-6.
PMID: 34622243
PMC: 8349422.
DOI: 10.1016/j.athplu.2021.08.001.
Inflammation and Cardiovascular Disease: The Future.
Arnold N, Lechner K, Waldeyer C, Shapiro M, Koenig W
Eur Cardiol. 2021; 16:e20.
PMID: 34093741
PMC: 8157394.
DOI: 10.15420/ecr.2020.50.
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
Moriarty P, Gorby L, Stroes E, Kastelein J, Davidson M, Tsimikas S
Curr Atheroscler Rep. 2020; 22(9):48.
PMID: 32710255
PMC: 7381416.
DOI: 10.1007/s11883-020-00867-3.
A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter.
Coassin S, Hermann-Kleiter N, Haun M, Wahl S, Wilson R, Paulweber B
PLoS One. 2020; 15(4):e0232073.
PMID: 32343731
PMC: 7188291.
DOI: 10.1371/journal.pone.0232073.
DNA methylation profiling identifies a high effect genetic variant for lipoprotein(a) levels.
Jones G, Marsman J, Bhat B, Phillips V, Chatterjee A, Rodger E
Epigenetics. 2020; 15(9):949-958.
PMID: 32237968
PMC: 7518699.
DOI: 10.1080/15592294.2020.1739797.
Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials.
Sahebkar A, Simental-Mendia L, Pirro M, Banach M, Watts G, Sirtori C
Sci Rep. 2018; 8(1):17887.
PMID: 30552391
PMC: 6294784.
DOI: 10.1038/s41598-018-36204-7.